1. Coughlin, Curtis R, Swanson, Michael A, Kronquist, Kathryn, Scharer, Gunter H, Van Hove, Johan L K. 2016. The genetic basis of classic nonketotic hyperglycinemia due to mutations in GLDC and AMT. In Genetics in medicine : official journal of the American College of Medical Genetics, 19, 104-111. doi:10.1038/gim.2016.74. https://pubmed.ncbi.nlm.nih.gov/27362913/
2. Zhou, Jie, Wang, Dong, Wong, Bosco Ho-Yin, To, Kelvin Kai-Wang, Yuen, Kwok Yung. . Identification and characterization of GLDC as host susceptibility gene to severe influenza. In EMBO molecular medicine, 11, . doi:10.15252/emmm.201809528. https://pubmed.ncbi.nlm.nih.gov/30498026/
3. Yuan, Yingli, Sun, Luguo, Wang, Xu, Li, Hongwei, Ma, Kewei. 2019. Identification of a new GLDC gene alternative splicing variant and its protumorigenic roles in lung cancer. In Future oncology (London, England), 15, 4127-4139. doi:10.2217/fon-2019-0403. https://pubmed.ncbi.nlm.nih.gov/31773974/
4. Min, Hyae Lim, Kim, Jin, Kim, Woo Ho, Jang, Bo Gun, Kim, Min A. . Epigenetic Silencing of the Putative Tumor Suppressor Gene GLDC (Glycine Dehydrogenase) in Gastric Carcinoma. In Anticancer research, 36, 179-87. doi:. https://pubmed.ncbi.nlm.nih.gov/26722042/
5. Liu, Rui, Zeng, Lin-Wen, Gong, Rong, Shu, Hong-Bing, Li, Shu. 2021. mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis. In Nature communications, 12, 4227. doi:10.1038/s41467-021-24321-3. https://pubmed.ncbi.nlm.nih.gov/34244482/
6. Xie, Huaying, Yan, Tingting, Lu, Xinxin, Zhou, Liheng, Ma, Jun. 2022. GLDC mitigated by miR-30e regulates cell proliferation and tumor immune infiltration in TNBC. In Frontiers in immunology, 13, 1033367. doi:10.3389/fimmu.2022.1033367. https://pubmed.ncbi.nlm.nih.gov/36275705/
智鼠故事 
